Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

7.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.3K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

480
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
480
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

4.8K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
4.8K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global incorporation of synthetic adenosine analogs reveals poly(A)-dependent translation differences in mRNA.

Bioorganic chemistry·2026
Same author

Epithelial FOXP3 Orchestrates O-Glycosylated IL6 Secretion to Drive Pancreatic Fibrocarcinogenesis.

Gastroenterology·2026
Same author

A nutrition-focused model for predicting postoperative complications in locally advanced gastric cancer after neoadjuvant chemotherapy: a retrospective cohort study.

BMC gastroenterology·2026
Same author

Boundary-Aware Attention with Dual-Stream Frequency Fusion for Medical Image Segmentation.

IEEE journal of biomedical and health informatics·2026
Same author

A personalized prognostic model based on preoperative body composition and nutritional parameters for gastric cancer patients receiving neoadjuvant chemotherapy.

Frontiers in immunology·2026
Same author

Metabolic signatures of lipid dysregulation and inflammation characterize pancreatic cancer risk in type 2 diabetes mellitus and improve risk stratification: a prospective cohort study.

Diabetes research and clinical practice·2026
Same journal

Non-contact Heart Sound Measurement by Defocused Speckle Imaging.

IEEE journal of biomedical and health informatics·2026
Same journal

TaxEL: Taxonomy-Enhanced Entity Representation Learning for Biomedical Entity Linking.

IEEE journal of biomedical and health informatics·2026
Same journal

Multimodal Feature Prototype Learning for Interpretable and Discriminative Cancer Survival Prediction.

IEEE journal of biomedical and health informatics·2026
Same journal

CrossSG-DTA: Synergizing Sequence Semantics and Graph Structures via Cross-Attention for Drug-Target Affinity Prediction.

IEEE journal of biomedical and health informatics·2026
Same journal

FGCSA-Net: A Novel Framework for Medical Report Generation Via Fine-Grained Feature Preservation and Semantic Alignment.

IEEE journal of biomedical and health informatics·2026
Same journal

Med-SORA: Symptom to Organ Reasoning in Abdomen CT Images.

IEEE journal of biomedical and health informatics·2026
See all related articles

Related Experiment Video

Updated: May 24, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.4K

MHAN-DTA: A Multiscale Hybrid Attention Network for Drug-Target Affinity Prediction.

Jiaren Li, Xiangpeng Bi, Wenjian Ma

    IEEE Journal of Biomedical and Health Informatics
    |March 3, 2025
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces MHAN-DTA, a novel deep learning model for drug-target affinity prediction. MHAN-DTA enhances feature extraction for improved drug discovery performance.

    More Related Videos

    Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
    06:50

    Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

    Published on: January 26, 2024

    1.1K
    Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
    08:31

    Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

    Published on: December 1, 2020

    4.9K

    Related Experiment Videos

    Last Updated: May 24, 2025

    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    18.4K
    Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
    06:50

    Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

    Published on: January 26, 2024

    1.1K
    Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
    08:31

    Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

    Published on: December 1, 2020

    4.9K

    Area of Science:

    • Computational chemistry
    • Bioinformatics
    • Drug discovery

    Background:

    • Drug-target affinity prediction is crucial for efficient drug discovery.
    • Current deep learning methods inadequately represent drug-target interactions, limiting predictive accuracy.

    Purpose of the Study:

    • To develop an advanced deep learning model, MHAN-DTA, for more effective drug-target affinity prediction.
    • To improve the mining of multiscale features within drug-target binding sites.

    Main Methods:

    • Proposed a Multiscale Hybrid Attention Network (MHAN-DTA) incorporating a pocket-oriented feature aggregation module with self-attention.
    • Implemented a hierarchical strategy for target proteins and cross-modal/entity interaction modules.
    • Utilized four benchmark datasets for comprehensive model evaluation.

    Main Results:

    • MHAN-DTA demonstrated superior and robust performance across all tested datasets.
    • The model effectively addresses insufficient feature mining in existing drug-target affinity prediction approaches.
    • The proposed architecture enhances the global perception and feature extraction capabilities.

    Conclusions:

    • MHAN-DTA offers a significant advancement in drug-target affinity prediction accuracy and reliability.
    • The model's architecture provides a powerful framework for mining complex interactions in drug discovery.
    • Publicly available code facilitates further research and application in the field.